SCHEMBL987824

SCHEMBL987824

COc1ccc(CN(CC#CCOC(C)CC#CCOc2ccccc2)CCC#N)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 3/20 0.44
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 2/20 0.36
KCNH2 Q12809 3/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
NR1H3 Q13133 2/20 0.34
PBRM1 Q86U86 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
CCR6 P51684 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MMP2 P08253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL987821 1.00 ALDH1A1 (0.44) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL12923939 0.90 CYP3A4 (0.40) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL988232 0.85 ALDH1A1 (0.38) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL988230 0.85 ALDH1A1 (0.38) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL12949289 0.76 TSHR (0.44) ALDH1A1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL988223 0.73 CYP2D6 (0.35) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL988222 0.73 CYP2D6 (0.35) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19
SCHEMBL12949521 0.73 ALDH1A1 (0.35) ALDH1A1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL12949388 0.73 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL12923940 0.72 ALDH1A1 (0.35) ALDH1A1KDM4ECYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003776-A1 TETRAHYDROPYRANONAPHTHYRIDINES DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC TREATMENT THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003776-A1 TETRAHYDROPYRANONAPHTHYRIDINES DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC TREATMENT THEREOF TPMT, TYMS, QDPR ALDH1A1 1282/4885KDM4E 2763/4885CYP3A4 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.